Veterinary Medicines

Canergy 100 mg Tablets for Dogs

Authorised
  • Propentofylline
Download as PDF

Product identification

Medicine name:
Canergy 100 mg Tablets for Dogs
Canergy 100 mg tablety pre psy
Active substance:
  • Propentofylline
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Propentofylline
    100.00
    milligram(s)
    /
    1.00
    Piece
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC04AD90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:
  • Cardboard box with 7 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 6 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 50 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 5 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 4 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 3 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 25 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 2 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 10 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 1 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 9 Aluminium - PA_ALU_PVC blister of 10 tablets
  • Cardboard box with 8 Aluminium - PA_ALU_PVC blister of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Artesan Pharma GmbH & Co. KG
  • Lelypharma B.V.
  • Genera d.d.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/081/DC/15-S
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0313/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 21/02/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."